FDA posts laboratory testing results for NDMA levels in metformin

U.S. FDA has determined that the levels of NDMA in metformin products tested range from not detectable to low levels. To date, no sample of metformin that has been tested exceeds the acceptable daily intake for NDMA. Therefore FDA has not recommended metformin recalls in the U.S.


US Food and Drug Administration